Hyfusin Group Holdings Limited (8512.HK)
HKD 0.31
(0.0%)
HKD 0.31
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 335.54 Million HKD | 61.56% |
| 2022 | 207.69 Million HKD | -23.05% |
| 2021 | 269.92 Million HKD | 30.65% |
| 2020 | 206.6 Million HKD | 126.36% |
| 2019 | 91.27 Million HKD | 87.75% |
| 2018 | 48.61 Million HKD | 18.22% |
| 2017 | 41.12 Million HKD | -6.03% |
| 2016 | 43.76 Million HKD | 6.41% |
| 2015 | 41.12 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 83.89 Million HKD | 0.0% |
| 2024 Q1 | 83.89 Million HKD | -57.78% |
| 2023 FY | 335.54 Million HKD | 61.56% |
| 2023 Q4 | 198.7 Million HKD | 60.61% |
| 2023 Q1 | 53.47 Million HKD | -8.84% |
| 2023 Q2 | 83.36 Million HKD | 55.9% |
| 2023 Q3 | 123.72 Million HKD | 48.42% |
| 2022 Q1 | 44.05 Million HKD | -42.04% |
| 2022 FY | 207.69 Million HKD | -23.05% |
| 2022 Q4 | 58.65 Million HKD | 13.41% |
| 2022 Q3 | 51.72 Million HKD | -2.89% |
| 2022 Q2 | 53.25 Million HKD | 20.88% |
| 2021 Q1 | 47.54 Million HKD | -47.48% |
| 2021 Q2 | 67.69 Million HKD | 42.4% |
| 2021 Q3 | 78.66 Million HKD | 16.2% |
| 2021 Q4 | 76.01 Million HKD | -3.37% |
| 2021 FY | 269.92 Million HKD | 30.65% |
| 2020 Q2 | 24.16 Million HKD | -2.23% |
| 2020 Q1 | 24.71 Million HKD | -21.45% |
| 2020 Q3 | 67.2 Million HKD | 178.12% |
| 2020 Q4 | 90.52 Million HKD | 34.71% |
| 2020 FY | 206.6 Million HKD | 126.36% |
| 2019 Q4 | 31.46 Million HKD | -7.59% |
| 2019 FY | 91.27 Million HKD | 87.75% |
| 2019 Q3 | 34.05 Million HKD | 173.77% |
| 2019 Q2 | 12.43 Million HKD | -6.61% |
| 2019 Q1 | 13.31 Million HKD | -7.98% |
| 2018 Q3 | 16.51 Million HKD | 52.9% |
| 2018 Q1 | 6.82 Million HKD | -22.06% |
| 2018 Q4 | 14.47 Million HKD | -12.37% |
| 2018 FY | 48.61 Million HKD | 18.22% |
| 2018 Q2 | 10.8 Million HKD | 58.29% |
| 2017 Q3 | 18.73 Million HKD | 140.17% |
| 2017 Q1 | 6.81 Million HKD | 0.0% |
| 2017 Q2 | 7.8 Million HKD | 14.45% |
| 2017 Q4 | 8.75 Million HKD | -53.27% |
| 2017 FY | 41.12 Million HKD | -6.03% |
| 2016 FY | 43.76 Million HKD | 6.41% |
| 2015 FY | 41.12 Million HKD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 200.34 Million HKD | -67.482% |
| Innovative Pharmaceutical Biotech Limited | 840 Thousand HKD | -39845.357% |
| China Overseas Nuoxin International Holdings Limited | 35.69 Million HKD | -840.128% |
| Prosperous Future Holdings Limited | 71.05 Million HKD | -372.233% |
| Huasheng International Holding Limited | 154.45 Million HKD | -117.239% |
| Fourace Industries Group Holdings Limited | 95.5 Million HKD | -251.341% |
| Evergreen Products Group Limited | 233.23 Million HKD | -43.865% |
| EC Healthcare | 704.74 Million HKD | 52.388% |
| Ming Fai International Holdings Limited | 488.74 Million HKD | 31.347% |
| Blue Moon Group Holdings Limited | 4.35 Billion HKD | 92.3% |
| SuperRobotics Holdings Limited | 7.28 Million HKD | -4508.447% |
| Takbo Group Holdings Limited | 75.4 Million HKD | -344.985% |